Recent news on Deferoxamine

FDA - MedWatch - Exjade (deferasorix) Tablets For Oral Suspension ...  -  May 22, 2007
PharmaLive.com (press release),Nonprogressive increases in serum creatinine have been noted in 38% of Exjade-treated patients, compared to 14% of deferoxamine-treated patients,

Data Presented At The International Symposium On Myelodysplastic ...  -  May 18, 2007
Medical News Today (press release),There are some drugs which can help chelate, or bind to iron to help remove it from the body, such as deferoxamine and deferasirox, and can reduce the

New data support long term use of once – daily Exjade® to reduce ...  -  Mar 13, 2007
ArabianBusiness.com,Exjade was developed to meet the high unmet need for an oral iron chelator despite the availability of deferoxamine (Desferal).

Acetaminophen Protects Against Iron-Induced Cardiac Damage in Gerbils  -  Feb 20, 2007
Annals of Clinical & Laboratory Science (subscription),Acetaminophen and deferoxamine treatments were given on Mondays, Wednesdays, and Fridays during the same 8 wk and continued for 4 wk after completion of

FTC Challenges Hospira/Mayne Pharma Deal  -  18 Jan 2007
PharmaLive.com (press release),Deferoxamine Mesylate. Injectable deferoxamine is an iron chelator used to treat acute iron poisoning or chronic iron overload.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional